EUVIMEDEUVIMED entdecken
Crossref

RH5: rationally-designed malaria vaccine antigen improving efficacy

Eizo Takashima, Takafumi Tsuboi

Trends in Parasitology · 2024

DOI: 10.1016/j.pt.2024.09.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Parasitology, 2024. Verfasst von Eizo Takashima und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan. Hauptthemen laut MEDLINE: Antigens, Protozoan, Malaria Vaccines, Malaria, Falciparum, Plasmodium falciparum. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) is a unique asexual blood-stage malaria vaccine candidate because of its high conservation and essential biological function of binding to basigin on the erythrocyte surface. Recent studies by Barrett et al., Wang et al., and King et al., have brought RH5-based vaccine development a step forward based on a rational antigen design strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, ProtozoanMalaria VaccinesMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsAnimalsHumansErythrocytesVaccine DevelopmentCarrier Proteins

Stichwörter der Autor:innen

Plasmodium falciparumRH5VLPblood-stage malaria vaccineepitope mappinghuman monoclonal antibodies

Substanzen

Antigens, ProtozoanMalaria VaccinesProtozoan ProteinsRH5 protein, Plasmodium falciparumCarrier Proteins

Autor:innen und Institutionen

  • Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
  • Division of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan. Electronic address: tsuboi.takafumi.mb@ehime-u.ac.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Takashima, E., & Tsuboi, T. (2024). RH5: rationally-designed malaria vaccine antigen improving efficacy. Trends in Parasitology. https://doi.org/10.1016/j.pt.2024.09.001

Vancouver

Takashima E, Tsuboi T. RH5: rationally-designed malaria vaccine antigen improving efficacy. Trends in Parasitology. 2024. doi:10.1016/j.pt.2024.09.001

BibTeX
@article{Takashima2024,
  author = {Takashima, Eizo and Tsuboi, Takafumi},
  title = {RH5: rationally-designed malaria vaccine antigen improving efficacy},
  journal = {Trends in Parasitology},
  year = {2024},
  doi = {10.1016/j.pt.2024.09.001}
}
Kostenlos starten →